SEC Form 4 · accession 0000885590-17-000019
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Appio
Officer — EVP, COMPANY GROUP CHAIRMAN
Period of report
Mar 28, 2017
Accepted (ET)
Mar 30, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Mar 28, 2017 | A | 63,742 | $0.00 | A | 98,149 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the award of Restricted Share Units (RSUs) which will vest one-third (1/3) on August 17, 2017, one-third (1/3) on August 17, 2018 and one-third (1/3) on August 17, 2019. Vested RSUs are settled in common shares, no par value (Common Shares), of Valeant Pharmaceuticals International, Inc. (Valeant).